Literature DB >> 23980290

Cholera, 2012.

.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23980290

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  19 in total

Review 1.  Economics and financing of vaccines for diarrheal diseases.

Authors:  Sarah M Bartsch; Bruce Y Lee
Journal:  Hum Vaccin Immunother       Date:  2014-04-22       Impact factor: 3.452

2.  Cholera in travelers: shifting tides in epidemiology, management, and prevention.

Authors:  Katie Fillion; Maria D Mileno
Journal:  Curr Infect Dis Rep       Date:  2015-01       Impact factor: 3.725

Review 3.  Killed oral cholera vaccines: history, development and implementation challenges.

Authors:  Anna Lena Lopez; Maria Liza Antoinette Gonzales; Josephine G Aldaba; G Balakrish Nair
Journal:  Ther Adv Vaccines       Date:  2014-09

Review 4.  Commercializing diarrhea vaccines for travelers.

Authors:  Rosa López-Gigosos; Marina Segura-Moreno; Rosa Díez-Díaz; Elena Plaza; Alberto Mariscal
Journal:  Hum Vaccin Immunother       Date:  2014-02-04       Impact factor: 3.452

Review 5.  Maximizing protection from use of oral cholera vaccines in developing country settings: an immunological review of oral cholera vaccines.

Authors:  Sachin N Desai; Alejandro Cravioto; Dipika Sur; Suman Kanungo
Journal:  Hum Vaccin Immunother       Date:  2014-05-26       Impact factor: 3.452

6.  Conjugated Linoleic Acid Reduces Cholera Toxin Production In Vitro and In Vivo by Inhibiting Vibrio cholerae ToxT Activity.

Authors:  Jeffrey H Withey; Dhrubajyoti Nag; Sarah C Plecha; Ritam Sinha; Hemanta Koley
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

7.  Mechanism for inhibition of Vibrio cholerae ToxT activity by the unsaturated fatty acid components of bile.

Authors:  Sarah C Plecha; Jeffrey H Withey
Journal:  J Bacteriol       Date:  2015-03-02       Impact factor: 3.490

8.  Relationship between Distinct African Cholera Epidemics Revealed via MLVA Haplotyping of 337 Vibrio cholerae Isolates.

Authors:  Sandra Moore; Berthe Miwanda; Adodo Yao Sadji; Hélène Thefenne; Fakhri Jeddi; Stanislas Rebaudet; Hilde de Boeck; Bawimodom Bidjada; Jean-Jacques Depina; Didier Bompangue; Aaron Aruna Abedi; Lamine Koivogui; Sakoba Keita; Eric Garnotel; Pierre-Denis Plisnier; Raymond Ruimy; Nicholas Thomson; Jean-Jacques Muyembe; Renaud Piarroux
Journal:  PLoS Negl Trop Dis       Date:  2015-06-25

9.  Oral Cholera Vaccine Coverage, Barriers to Vaccination, and Adverse Events following Vaccination, Haiti, 2013.

Authors:  Rania A Tohme; Jeannot François; Kathleen Wannemuehler; Preetha Iyengar; Amber Dismer; Paul Adrien; Terri B Hyde; Barbara J Marston; Kashmira Date; Eric Mintz; Mark A Katz
Journal:  Emerg Infect Dis       Date:  2015-06       Impact factor: 6.883

10.  Flexibility of oral cholera vaccine dosing-a randomized controlled trial measuring immune responses following alternative vaccination schedules in a cholera hyper-endemic zone.

Authors:  Suman Kanungo; Sachin N Desai; Ranjan Kumar Nandy; Mihir Kumar Bhattacharya; Deok Ryun Kim; Anuradha Sinha; Tanmay Mahapatra; Jae Seung Yang; Anna Lena Lopez; Byomkesh Manna; Barnali Bannerjee; Mohammad Ali; Mandeep Singh Dhingra; Ananga Mohan Chandra; John D Clemens; Dipika Sur; Thomas F Wierzba
Journal:  PLoS Negl Trop Dis       Date:  2015-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.